Literature DB >> 11223366

Modifications in gonadotropin signaling: a key to understanding cyclic ovarian function.

A J Zeleznik1.   

Abstract

The enigma in understanding the regulation of ovarian function throughout the menstrual cycle is that both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) act on the ovary, at least in part through the cyclic adenosine monophosphate (cAMP) intracellular signaling pathway. If cAMP is a common intracellular messenger of gonadotropic stimulation during both the follicular and the luteal phases, how can the responses of the follicle and the corpus luteum to their respective trophic hormones differ so dramatically? The actions of FSH and LH on the ovary are summarized and a mechanistic hypothesis is provided as to how ovarian cyclicity (initiation of follicular development, selection of a single preovulatory follicle, corpus luteum function, corpus luteum regression, and corpus luteum rescue during early pregnancy) could be controlled by a single intracellular messenger: cAMP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223366     DOI: 10.1016/s1071-5576(00)00101-5

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  3 in total

Review 1.  Analysis of microarray data from the macaque corpus luteum; the search for common themes in primate luteal regression.

Authors:  C V Bishop; R L Bogan; J D Hennebold; R L Stouffer
Journal:  Mol Hum Reprod       Date:  2010-09-20       Impact factor: 4.025

2.  Luteinizing hormone receptor mRNA down-regulation is mediated through ERK-dependent induction of RNA binding protein.

Authors:  Bindu Menon; Megan Franzo-Romain; Shadi Damanpour; K M J Menon
Journal:  Mol Endocrinol       Date:  2010-12-08

3.  Comparison of endocrine and cellular mechanisms regulating the corpus luteum of primates and ruminants.

Authors:  M C Wiltbank; S M Salih; M O Atli; W Luo; C L Bormann; J S Ottobre; C M Vezina; V Mehta; F J Diaz; S J Tsai; R Sartori
Journal:  Anim Reprod       Date:  2012-07       Impact factor: 1.807

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.